Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies.
Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies.
复制标题
SARS-COV-2和其他病因的机械通风患者和急性低氧呼吸衰竭的机械通风患者的结局。
DOI:
10.1001/jamanetworkopen.2022.50401
复制
发表时间:
2023-01-03
影响因子:
13.8
通讯作者:
Checkley, William
中科院分区:
文献类型:
--
作者:
Nolley, Eric P.;Sahetya, Sarina K.;Hochberg, Chad H.;Hossen, Shakir;Hager, David N.;Brower, Roy G.;Stuart, Elizabeth A.;Checkley, William
Does COVID-19 pneumonia have a higher mortality rate than other causes of pneumonia? In this cohort study of 1846 patients with pneumonia, COVID-19 pneumonia had similar mortality rates and physiologic phenotypes as other causes of pneumonia. These findings suggest that mechanical ventilation use in COVID-19 pneumonia should follow the same evidence-based guidelines as any pneumonia. This cohort study compares outcomes between mechanically ventilated patients with pneumonia due to COVID-19 and other etiologies. Early observations suggested that COVID-19 pneumonia had a higher mortality rate than other causes of pneumonia. To compare outcomes between mechanically ventilated patients with pneumonia due to COVID-19 (March 2020 to June 2021) and other etiologies (July 2016 to December 2019). This retrospective cohort study was conducted at the Johns Hopkins Healthcare System among adult patients (aged ≥18 years) with pneumonia who required mechanical ventilation in the first 2 weeks of hospitalization. Clinical, laboratory, and mechanical ventilation data were extracted from admission to hospital discharge or death. Pneumonia due to COVID-19. The primary outcome was 90-day in-hospital mortality. Secondary outcomes were time to liberation from mechanical ventilation, hospital length of stay, static respiratory system compliance, and ventilatory ratio. Unadjusted and multivariable-adjusted logistic regression, proportional hazards regression, and doubly robust regression were used in propensity score–matched sets to compare clinical outcomes. Overall, 719 patients (mean [SD] age, 61.8 [15.3] years; 442 [61.5%] were male; 460 [64.0%] belonged to a minoritized racial group and 253 [35.2%] were White) with severe COVID-19 pneumonia and 1127 patients (mean [SD] age, 60.9 [15.8] years; 586 [52.0%] were male; 459 [40.7%] belonged to a minoritized racial group and 655 [58.1%] were White) with severe non–COVID-19 pneumonia. In unadjusted analyses, patients with COVID-19 pneumonia had higher 90-day mortality (odds ratio, 1.21, 95% CI 1.04-1.41), longer time on mechanical ventilation (subdistribution hazard ratio 0.72, 95% CI 0.63-0.81), and lower compliance (32.0 vs 28.4 mL/kg PBW/cm H2O; P < .001) when compared with those with non–COVID-19 pneumonia. In propensity score–matched analyses, patients with COVID-19 pneumonia were equally likely to die within 90 days as those with non–COVID-19 pneumonia (odds ratio, 1.04; 95% CI, 0.81 to 1.35; P = .85), had similar respiratory system compliance (mean difference, 1.82 mL/cm H2O; 95% CI, −1.53 to 5.17 mL/cm H2O; P = .28) and ventilatory ratio (mean difference, −0.05; 95% CI, −0.22 to 0.11; P = .52), but had lower rates of liberation from mechanical ventilation (subdistribution hazard ratio, 0.81; 95% CI, 0.65 to 1.00) when compared with those with non–COVID-19 pneumonia. Patients with COVID-19 pneumonia had somewhat lower rates of being discharged from the hospital alive at 90 days (subdistribution hazard ratio, 0.83; 95% CI, 0.68 to 1.01) than those with non–COVID-19 pneumonia; however, this was not statistically significant. In this study, mechanically ventilated patients with severe COVID-19 pneumonia had similar mortality rates as patients with other causes of severe pneumonia but longer times to liberation from mechanical ventilation. Mechanical ventilation use in COVID-19 pneumonia should follow the same evidence-based guidelines as for any pneumonia.
登录
查看更多内容
影响因子:
8.3
作者:
Cobb NL;Sathe NA;Duan KI;Seitz KP;Thau MR;Sung CC;Morrell ED;Mikacenic C;Kim HN;Liles WC;Luks AM;Town J;Pipavath S;Wurfel MM;Hough CL;West TE;Bhatraju PK
通讯作者:
Bhatraju PK
影响因子:
38.9
作者:
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
通讯作者:
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
DOI:
10.1186/s13054-021-03665-8
发表时间:
2021-07-15
期刊:
Critical care (London, England)
影响因子:
--
作者:
Beloncle F;Studer A;Seegers V;Richard JC;Desprez C;Fage N;Merdji H;Pavlovsky B;Helms J;Cunat S;Mortaza S;Demiselle J;Brochard L;Mercat A;Meziani F
通讯作者:
Meziani F
影响因子:
38.9
作者:
Ferrando, Carlos;Suarez-Sipmann, Fernando;Villar, Jesus
通讯作者:
Villar, Jesus
影响因子:
15.1
作者:
Grieco, Domenico Luca;Bongiovanni, Filippo;Antonelli, Massimo
通讯作者:
Antonelli, Massimo